Underwriting Breast Cancer

Slides:



Advertisements
Similar presentations
UNDERWRITING CORRELATION FOR CANCER CASES. Are we going to accept a proposed insured with known cancer?
Advertisements

STAGING MCR Staff Show Me Healthy Women March 27, 2008 Supported by a Cooperative Agreement between DHSS and the Centers for Disease Control and Prevention.
AJCC Staging Moments AJCC TNM Staging 7th Edition Rectal Case #3 Contributors: J. Milburn Jessup, MD Cancer Diagnosis Program, DCTD, NCI, Rockville, Maryland.
AJCC TNM Staging 7th Edition Thyroid Case #3
AJCC TNM Staging 7th Edition Colon Case #1
Controversies in Breast Cancer Allan Arkush, DO, FACOS.
CREATED EXCLUSIVELY FOR FINANCIAL PROFESSIONALS Underwriting Foreign Residence and Travel Life insurance is issued by The Prudential Insurance Company.
A program of the UAMS College of Pharmacy
Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery
Geonomics in Breast Cancer Decoding Human Genome Luis Barreras, M.D., FACP.
AJCC TNM Staging 7th Edition Breast Case #3
Breast Imaging Made Brief and Simple
The All Breast Cancer Report was published in October breastscreen/research.html#breast- cancer-report.
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Breast Cancer Early detection of disease Precise Staging.
AJCC TNM Staging 7th Edition Melanoma Case #2
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #2 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
AJCC Staging Moments AJCC TNM Staging 7th Edition Colon Case #2 Contributors: J. Milburn Jessup, MD Cancer Diagnosis Program, DCTD, NCI, Rockville, Maryland.
Racial/Ethnic Disparities in Cancer Incidence, Survival and Treatment Linda C. Harlan, PhD, MPH National Cancer Institute Division of Cancer Control and.
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #1 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
SYB Case 2 By: Amy. History 63 y/o female History of left breast infiltrating duct carcinoma s/p mastectomy in 1996 and chemotherapy ER negative, PR negative,
Breast Carcinoma. Anatomy Epidemiology: 10% 17.1/10 28/10 46/ m world wide 6% develop cancer of the breast in their lifetime. 50,000 to 70,000.
Cancer Staging.
MAMMOGRAPHY - Pt 2 EQUIPMENT LECTURE & more….. RTEC 255 Week # 3 D. CHARMAN, M.Ed.,R.T.(R,M)
Putting the Puzzle Together: Breast Collaborative Staging Melissa Riddle, RHIT, CTR October 6, 2012.
NYU Medical Grand Rounds Clinical Vignette Daniel P. Eiras, MD, MPH PGY2 December 1, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
TREATMENT Mastectomy -traditionally, treatment of breast ca has been surgical -19 century, surgical treatment : local excision ~ total mastectomy : radical.
 Among all cancers, breast cancer has been the 2 nd leading cause of death in women (right behind lung cancer)  Causes about 40,000 deaths annually.
Understanding Cancer and Related Topics
Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.
Pathology.
Breast Cancer 1. Leukemia & Lymphoma New diagnoses each year in the US: 112, 610 Adults 5,720 Children 43,340 died of leukemia or lymphoma in
Cancer: Staging and Grading What is meant by the term “biopsy”? How do tumors behave differently from one another ? Examples of the stages of cancer and.
CLINICAL ASPECT OF GRADING AND STAGING Hanggoro Tri Rinonce, MD, PhD Department of Anatomical Pathology Faculty of Medicine, Gadjah Mada University.
What is Breast Cancer ? Abnormal cells develop from normal cells in the breast to form tumors Abnormal cells develop from normal cells in the breast to.
TMIST A Breast Cancer Screening Trial
Cancer Screening Guidelines
THE IMPORTANCE OF STAGING AND PROGNOSTIC FACTORS IN CANCER CARE
Case 3 Jane McNicholas Consultant Oncoplastic Breast Surgeon
TRIPLE NEGATIVE BREAST CANCER (TNBC) & ETHNIC MINORITIES
Ari Brooks, MD Cancer Surgeon, Big Data End User
Breast Cancer Protocol
Prognostic significance of tumor subtypes in male breast cancer:
Dr.Nik Makretsov, MD, PhD, FRCPC
BREAST CANCER A full classification includes histopathological type, grade, stage (TNM), receptor status, and the presence or absence of genes as determined.
Principles of Surgical Oncology
Case scenario- Breast Lump
BREAST CANCER Walid Galal El Shazly
UNDERWRITING CANCER OUR WAY OR THE LONG WAY
Prognosis of younger patients in non-small cell lung cancer
Case scenario- Breast Lump
Male and Female Reproductive Health Concerns
From: Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 YearsA Comparative Modeling Study of Risk Ann Intern.
Supplementary Table 1. (A) S100β Validation set (n=76 ER-positive and ER-negative patients). (B) S100β Validation set (n=59 ER-positive patients). Association.
Thanh Nhan Hospital MALE BREAST CANCER: CASE REPORT
Breast Health Katherine B. Lee, MD, FACP April 26, 2018.
Breast Imaging Ravi Adhikary, MD.
徐慧萍1 羅竹君1,2 郭耀隆1 李國鼎1 國立成功大學醫學院附設醫院外科部1 國立成功大學醫學院臨床醫學研究所2
Cancer Staging.
Effect of Obesity on Prognosis after Early Breast Cancer
Treatment Overview: The Multidisciplinary Team
Handling and Evaluation of Breast Cancer Biopsy
Stamatia Destounis, MD, FACR, FSBI, FAIUM
Cancer 101: A Cancer Education and Training Program for [Target Population] Date Location Presented by: Presenter 1 Presenter 2 1.
20-Year Risks of Breast-Cancer Recurrence
Marion C.W. Henry, MD Yale University
Nadia Howlader, PhD National Cancer Institute
Principles and Practice of Radiation Therapy
NSCLC: Staging and TNM classification
Dr. Damjanovich László Dr. Fülöp Balázs
Presentation transcript:

Underwriting Breast Cancer [Presenter Name, Title] The Prudential Insurance Company of America, Newark, NJ NOT FOR CONSUMER USE. 0251209-00002-00 Ed. 3/2015 Exp. 03/5/2017

Description Breast Cancer Breast cancer is the most common cancer in women in the United States and second only to lung cancer as a cause of cancer deaths. Some cancers are discovered when a woman finds a palpable mass in her breast. Most cases are diagnosed by screening mammography (breast X-ray). The diagnosis of breast cancer is made by biopsy. Staging is done to determine the prognosis, to direct therapies, and to report results in treatment research studies. The staging system of the American Joint Committee on Cancer Staging uses TNM (tumor, node, metastasis) classification. The primary tumor is evaluated by size, involvement of other tissues, status node, and presence or absence of distant metastasis. Non-invasive cancer (aka in-situ) has a better prognosis than invasive tumors. Tumor size is an independent prognostic factor. Each involved node worsens the prognosis. For breast cancer, the mortality risk varies with the stage of the cancer. NOT FOR CONSUMER USE.

Underwriting Criteria Breast Cancer Reports Needed and Critical Information for Risk Assessment Pathology report/age at diagnosis. Stage, nodal involvement, and size of tumor Best Case Scenario (Non-Smokers) Stage 1A (T1 N0) and Stage 0 in-situ (T1 N0) – Standard rates if greater than or equal to 40 years old (at diagnosis) with small (less than or equal to 1 mm), low grade, estrogen receptor (ER) positive tumors and normal annual mammograms. Unable to Offer Greater than 3 nodes positive or nodes other than axillary or intramammary ( a 15 year postponement period, then individual consideration) Stages 3 and 4 (a 15 year postponement period, then individual consideration) NOT FOR CONSUMER USE.

Case Studies Susan Susan is a 60-year-old female with the following breast cancer history: • Diagnosis at age 58. • Low grade, estrogen receptor (ER) positive. • Tumor size is 1.1mm and node negative (T1a N0) Classification Under our guidelines, the final classification is Non-Smoker Plus with no postponement. NOT FOR CONSUMER USE.

Case Studies Sally Sally is a 47-year-old female with the following breast cancer history: • Diagnosed at age 40. • Treatment ended at age 42. • Tumor size is 1.5 cm and 1 node positive (T1 N1). Classification Table B with Temporary Extra of $10.00 per thousand for 6 years, after postponement of 5 years from end of treatment. NOT FOR CONSUMER USE.

Questions? NOT FOR CONSUMER USE.

Important Information Case studies are for example purposes only. This material is intended for insurance informational purposes only and is not personal medical advice for clients. Rates and availability will vary based on the satisfaction of our underwriting criteria. Underwriting rules are subject to change at the company’s discretion. Insurance is issued by The Prudential Insurance Company of America and its affiliates, Newark, NJ. . NOT FOR CONSUMER USE.